ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	134	167	277	600	227	428
Market Cap Growth	8.22%	-39.78%	-53.81%	164.02%	-46.89%	-15.11%
Enterprise Value	44	57	200	455	176	317
PE Ratio	-	-5.34	-4.04	-8.69	-4.00	-6.74
PS Ratio	9.16	15.76	59.73	221.91	19.70	196.89
PB Ratio	3.59	3.63	3.88	4.64	3.26	4.04
P/FCF Ratio	-5.21	5.33	-3.76	-19.96	-3.96	-8.43
P/OCF Ratio	-4.41	6.97	-3.80	-20.29	-4.04	-8.53
EV/Sales Ratio	3.04	5.35	43.03	168.44	15.31	145.98
EV/EBITDA Ratio	-3.69	-2.10	-3.31	-7.30	-3.61	-5.30
EV/EBIT Ratio	-3.32	-1.90	-3.17	-7.00	-3.41	-5.11
EV/FCF Ratio	-2.67	1.81	-2.71	-15.15	-3.08	-6.25
Debt / Equity Ratio	0.55	0.48	0.33	0.53	0.60	0.14
Debt / EBITDA Ratio	-0.81	-0.81	-0.39	-1.10	-0.86	-0.25
Debt / FCF Ratio	-0.58	0.70	-0.32	-2.28	-0.73	-0.30
Quick Ratio	3.10	3.52	7.33	6.92	7.73	10.35
Current Ratio	3.11	3.54	7.36	6.94	7.77	10.43
Asset Turnover	0.10	0.07	0.03	0.01	0.09	0.02
Interest Coverage	-62.19	-18.34	-11.55	-16.80	-10.53	-51.03
Return on Equity (ROE)	-61.60%	-56.70%	-80.50%	-59.20%	-64.70%	-73.80%
Return on Assets (ROA)	-19.50%	-19.20%	-38.90%	-36.90%	-45.90%	-57.90%
Return on Capital (ROIC)	-56.52%	-52.12%	-73.18%	-32.84%	-46.37%	-53.24%
Earnings Yield	-21.72%	-18.73%	-24.74%	-11.51%	-25.00%	-14.84%
FCF Yield	-26.34%	18.77%	-26.58%	-5.01%	-25.23%	-11.87%
Buyback Yield / Dilution	-0.84%	-13.08%	-11.62%	-28.21%	-21.99%	-20.51%
Total Shareholder Return	-0.84%	-13.08%	-11.62%	-28.21%	-21.99%	-20.51%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).